Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
Zynerba Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 25, 2022
Zynerba Pharmaceuticals reported fiscal year 2021 executive compensation information on April 25, 2022.
In 2021, three executives at Zynerba Pharmaceuticals received on average a compensation package of $1.7M, a 44% increase compared to previous year.
Average pay of disclosed executives at Zynerba Pharmaceuticals
Armando Anido, Chief Executive Officer, received $2.2M in total, which increased by 49% compared to 2020. 35% of Anido's compensation, or $773K, was in stock awards. Anido also received $380K in non-equity incentive plan, $446K in option awards, $603K in salary, as well as $11K in other compensation.
Terri B. Sebree, President, received a compensation package of $1.6M, which increased by 44% compared to previous year. 33% of the compensation package, or $537K, was in stock awards.
James E. Fickenscher, Chief Financial Officer, earned $1.2M in 2021, a 35% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 25, 2022.